The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells.
| Image |  |
|---|---|
| Description | scientific article published on 21 February 2018 |
| Author/s |
author: Susanne M Rittig |
| Publication date | February 21, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |